Attend the Common Sense Oncology Symposium taking place at ESMO 2026 for an update on the movement and regional developments across the globe. Network with likeminded individuals and enjoy light refreshments. Speakers will give short talks about CSO-aligned activities in their respective countries. There will be time for attendees to ask questions and talk about what’s happening in their own systems. Where: ESMO venue, IFEMA, Madrid, Spain - Room A6.1 When: Friday, October 23, 2026 - 18:00 - 19:30 Speakers: Dr. Winnette van der Graaf, Dr. Dario Trapani, Dr. Chris Booth, Dr. Rodrigo Lastra, Dr. Francesco Perrone, Dr. Jolien Tol, Antonella Cardone Planning to attend? RSVP below to let us know! forms.gle/ckfCobUbPg15HMRB6 @myESMO #CommonSenseOncology #CancerCare

Are you an early-career oncologist looking to gain experience in health services research, cancer policy, and hands-on experience in the clinic? Common Sense Oncology invites you to apply for a one-year Cancer Health Services Research Fellowship in Kingston, Canada! Applications are due by September 1. Learn more and apply now: tinyurl.com/y8pdw3yv #CommonSenseOncology #CancerCare

Only two weeks left to apply! If you are a trainee or early career clinical or medical oncologist, Common Sense Oncology invites you to apply for its Cancer Health Services Research Fellowship at Queen’s University in Kingston, Canada. Applications due by September 1. Learn more and apply now:  tinyurl.com/y8pdw3yv Dr. Omar AbdiHamid @HamidMD10 was a CSO fellow in 2024 and is currently a Consultant Clinical Oncologist and cancer researcher in Kenya. He writes a blog that continues to advocate for common sense principles in oncology. In his latest post, he describes the thinking and inspiration behind his recent publication, Re-centering overall survival in oncology trials: Interpreting the FDA draft guidance through a global oncology lens, which is now available in the Journal of Cancer Policy. To learn more about CSO’s past fellows and to apply to be the next CSO Fellow in 2027, visit: commonsenseoncology.org/get-… Also check out Dr. AbdiHamid's blog here: omaryhamidy.substack.com/

Assista à gravação do primeiro webinar do Hub Brasil: piped.video/H01jzisTkZ4 #CommonSenseOncology #CancerCare

Não se esqueçam de se inscrever para o próximo webinar do Common Sense Oncology Hub Brasil que acontecerá no dia 14 de agosto, às 16h (Brasília, UTC-3:00)! Junte-se a nós online para uma discussão sobre terapia neoadjuvante para pacientes com câncer de mama HER2+ com base nos princípios de Common Sense Oncology. queensu.zoom.us/meeting/regi…

Cancer care in Norway has made remarkable progress, with more patients living longer than ever. But as new cancer treatments are approved faster, experts are urging a stronger focus on outcomes that truly matter: overall survival, quality of life, and realistic treatment goals. Read the new opinion piece by Common Sense Oncology Norway here: tinyurl.com/ymrj4cn5

The Values-to-Action Framework for Cancer Clinical Trials is about ensuring that cancer trials deliver outcomes that matter most to patients, including living longer and living better. It's a tool that can be used by trialists, ethics boards, funders, patient organizations, and others to help shape cancer clinical trial design and reporting. Learn more and access the tool here: tinyurl.com/mt4wesza #CommonSenseOncology #CancerCare

Are you an early-career oncologist looking to gain experience in health services research, cancer policy, and hands-on experience in the clinic? Common Sense Oncology invites you to apply for a one-year Cancer Health Services Research Fellowship in Kingston, Canada! Applications are due by September 1. Learn more and apply now:  tinyurl.com/y8pdw3yv

CSO Pacific Hub is meeting at the Medical Oncology Group of Australia's Annual Scientific Meeting! Join us on Wednesday, August 5th, at 11 am in Norfolk Hall to discuss ideas. Hear from Dr. Dario Trapani, Medical Oncologist at the European Institute of Oncology in Milan, Italy and Professor of Oncology and Haemato-Oncology at the University of Milan. He currently serves as the Chair of Cancer Medicines Committee at ESMO and is a member of various working groups of Common Sense Oncology. See you there! #CommonSenseOncology #CancerCare #MOGAASM @MOGA_ORG

Clinical trials have identified many important cancer treatments, yet concern exists that some trials prioritize regulatory approval over outcomes that matter most to patients, including meaningful improvement in survival and quality of life. The Values-to-Action Framework, developed by Common Sense Oncology in consultation with people from around the world with lived cancer experience, offers a practical tool to develop more ethical, inclusive, and relevant clinical trials. Read more about the tool on our website: tinyurl.com/mt4wesza #CommonSenseOncology #CancerCare

Brasil Hub: Controvérsias em oncologia clínica: tratamento do câncer de mama HER2 positivo localmente avançado Sexta feira 14/08/2026 | 16:00 (Brasília; UTC-3:00) Junte-se a nós online para uma discussão sobre terapia neoadjuvante para pacientes com câncer de mama HER2+ com base nos princípios de Common Sense Oncology. Cadastre-se aqui: tinyurl.com/276tc8bz #CommonSenseOncology #CancerCare

The Sinclair Cancer Research Institute (SCRI) at Queen's University in Kingston, Canada and Common Sense Oncology invite applications for a one-year Cancer Health Services Research Fellowship with an expected start date of July 1, 2027. This fellowship will provide hands-on training in health services research and cancer policy, as well as an opportunity to perform clinical work in medical oncology at Kingston Health Sciences Centre, one of Canada’s leading research and teaching hospitals. Learn more and apply: tinyurl.com/y8pdw3yv #CommonSenseOncology #CancerCare

Would you call it progress if a treatment is new, but does not help patients live longer or live better? Join the Common Sense Oncology track at #KICC2026 with Prof. Verna Vanderpuye, Dr Fidel Rubagumya, Dr Omar Abdihamid & Prof. Nazik Hammad. Register: bit.ly/4mWAXgf

In this episode of the Common Sense Oncology podcast, Dr. Richard Sullivan provides an update on the human crisis in cancer care and his work in progress on a global report for The World Bank. Tune in now! Spotify: tinyurl.com/269u38vu Apple Podcasts: tinyurl.com/yn5k9n8b #CommonSenseOncology #CancerCare

Ya disponible en YouTube: Escuche a especialistas en oncología analizar el enfoque de Common Sense Oncology en distintos países iberoamericanos y debatir los principales retos y oportunidades para la oncología global. Véalo aquí: piped.video/Vh0yF3eH4sI?si=2mIr… @GOCCHI #CommonSenseOncology #CáncerDePulmón #Oncología #AtenciónOncológica #OncologíaGlobal @DrRodrigoLastra

¡Gracias a todos los que participaron en el webinar de hoy sobre "Common Sense Oncology" en contexto iberoamericano! Si te lo perdiste, la grabación estará disponible pronto en nuestro canal de YouTube. ¡No te la pierdas! #CommonSenseOncology #CancerDePulmón #Oncología #CancerCare #GlobalOncology

Thanks to everyone who joined today's webinar about Common Sense Oncology in the Ibero-American context! In case you missed it, the recording will be released soon on our YouTube channel. Stay tuned! #CommonSenseOncology #CancerDePulmón #Oncología #CancerCare #GlobalOncology

A new comment in Nature Portfolio by Drs. Sam Stevens and Deme Karikios discusses need to rigorously evaluate outcomes following the decision to allow tumour-agnostic immunotherapy reimbursement in Australia. This bold policy experiment broadens drug availability, but carries an obligation to learn about patient outcomes, quality use of medicines, equity of access and toxicities so that health systems can serve patients in a way that sensibly balances speed, access and certainty with the best available evidence. doi.org/10.1038/s41571-026-0… #CommonSenseOncology #CancerCare #Nivolumab #Ipilimumab #TumorAgnostic #PrecisionOncology

Regístrate aquí: queensu.zoom.us/meeting/regi…

Scientific innovations in the cancer care space are to be celebrated for the amazing possibilities they can provide. However, these advances can sometimes seem to exist in a separate world from the lives of the very people who are treated by them, their families and communities. This year, ASCO was opened by an extraordinary plenary speech by Dr. Eric Small. In it, he highlighted gaps in the translation of healthcare innovations. Large gaps exist: in global and regional cancer care equity, in compassionate and accessible communications to patients from medical experts, and access to affordable and effective treatments. People with lived cancer experience deserve outcomes that matter. As Dr. Small said: Every cancer. Every patient. Everywhere. While advances should be implemented, health care systems should also prioritize treatments that deliver meaningful benefits to patients. Let's drive human-centred progress in oncology together. #CommonSenseOncology #CancerCare #ASCO2026